Serum Institute Of India
India  /  Published 21.07.21

Serum Institute asks for drug regulatory reforms

World's largest vaccine manufacturer by volume, Serum Institute of India (SII) has written to Union Health Minister Mansukh Mandaviya suggesting reforms in the existing drug regulatory system, inc...
By Our Bureau, PTI in New Delhi

India  /  Published 14.07.21

Serum signs pact to produce Sputnik V

By G.S. Mudur in New Delhi

India  /  Published 13.07.21

SII: Sputnik shots from September

Serum Institute of India (SII) will start production of Sputnik vaccine at the company's facilities in September, Russian Direct Investment Fund (RDIF) said on Tuesday. As per the agreement betwe...
By Our Bureau, PTI in New Delhi

India  /  Published 11.07.21

India's vaccine drive not as bad as it looks

First the good news – and then a host of qualifications. India’s vaccination drive’s been a jerky stop-and-start affair but it’s closer to its targets than might have been expe...
By Paran Balakrishnan in New Delhi

India  /  Published 30.06.21

Poonawalla: EU nod in a month

Vaccine major Serum Institute of India is confident of receiving approval from the European Medicines Agency (EMA) for its Covid-19 vaccine Covishield in a month, company's chief executive officer...
By Our Bureau, PTI in New Delhi


India  /  Published 29.06.21

Vaccine: EU travel a pain for Indians

Indian travellers who’ve had two shots of Covishield are out of luck if they want to travel to Europe under the European Union’s Digital Covid certificate. That’s despite the fact th...
By Paran Balakrishnan in New Delhi

India  /  Published 28.06.21

Covishield: SII prod to govt

Sources said referring to Poonawalla's letter, Director, Government and Regulatory Affairs at SII, Prakash Kumar Singh, has also sought Jaishankar's intervention at the highest level, saying, ...
By Our Bureau in Calcutta

India  /  Published 25.06.21

Poonawalla: Serum making 1st batch of Covovax

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII CEO Adar Poonawalla said on Friday. "Excit...
By Our Bureau, PTI in Pune

India  /  Published 15.06.21

Novovax: over 90% efficacy

By G.S. Mudur in New Delhi

Opinion  /  Published 07.06.21

The holes in the vaccine policy

The first phase of India’s Covid-19 mass vaccination programme was launched with healthcare professionals and other frontline workers on January 16, 2021. The second phase began on March 1; it w...
By Soumitra Ghosh


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.